Labcorp Has Completed The Acquisition Of Select Assets Of And Opko Health's Bioreference Health For $237.5M
Portfolio Pulse from Benzinga Newsdesk
Labcorp has completed the acquisition of select assets from Opko Health's BioReference Health for $237.5 million. The acquisition includes laboratory testing businesses focused on clinical diagnostics and reproductive and women's health, generating approximately $100 million in annual revenue.
September 16, 2024 | 11:38 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Opko Health has sold select assets of its BioReference Health to Labcorp for $237.5 million, which may impact its revenue stream.
The sale of assets may have a neutral short-term impact on Opko Health's stock as it loses a revenue stream but gains capital from the sale.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Labcorp has acquired select assets from Opko Health's BioReference Health for $237.5 million, enhancing its clinical diagnostics and women's health services.
The acquisition is likely to positively impact Labcorp's stock as it expands its service offerings and revenue base in clinical diagnostics and women's health, which are key growth areas.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90